JPRN-UMIN000003149Completed未知
Clinical trial of CDP-choline for the patients with corticobasal degeneration - CDP-choline treatment for CBD patients
Tadanori Hamano0 sites15 target enrollmentStarted: February 8, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 15
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 50years-old to 100years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The patients who showed allergy by previous CDP-choline injection.
Investigators
Similar Trials
Completed
Phase 3
Efficacy and Safety of CDP-choline in Patients With Methamphetamine DependenceMethamphetamine DependenceNCT01007539Seoul National University Hospital31
Completed
Not Applicable
A Randomised Placebo Controlled Trial of a Cholinesterase Inhibitor in the Management of Agitation in Dementia that is Unresponsive to a Psychological InterventioDementiaISRCTN62185868King's College London (UK)285
Completed
Not Applicable
A Clinical trial of compound drugs for patients with type2 diabetes - Comparative analysis of the characteristics of postprandial hyperglycemia improving drugs for postprandial metabolic disorder.type2 diabetesJPRN-UMIN000006199Advanced Clinical Research Organization12
Recruiting
Phase 2
Phase-2 clinical trial on the treatment of chronic dysphagia in head and neck cancer patients with dedicated strengthening exercises using the Swallow Exercise AidDysphagiaswallowing impairment10027656NL-OMON42230Antoni van Leeuwenhoek Ziekenhuis20
Completed
Not Applicable
effect of Duloxetine in treatment of ADHDAttention Deficit Hyperactivity Disorder(ADHD).Attention deficit: disorder with hyperactivity hyperactivity disorder syndrome with hyperactivityIRCT2012072210363N1niversity of Social Welfare and Rehabilitation Sciences10